| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.708 | 0.013 | 0.708 | Analgesic | 0.631 0.022 DBMET02576 0.632 0.022 DBMET02577 | ||
| 0.568 | 0.003 | 0.568 | Ca(v)2.2 blocker | 0.433 0.004 DBMET02576 0.454 0.004 DBMET02577 | ||
| 0.549 | 0.021 | 0.549 | Thioredoxin glutathione reductase inhibitor | 0.491 0.031 DBMET02576 0.361 0.072 DBMET02577 | ||
| 0.504 | 0.004 | 0.504 | Dopamine D4 agonist | 0.356 0.004 DBMET02576 0.336 0.004 DBMET02577 | ||
| 0.503 | 0.032 | 0.503 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.394 0.106 DBMET02576 0.346 0.155 DBMET02577 | ||
| 0.471 | 0.034 | 0.564 | Vasodilator, peripheral | 0.475 0.033 DBMET02576 0.564 0.02 DBMET02577 | DBMET02577 | |
| 0.423 | 0.004 | 0.423 | Nav1.1 sodium channel blocker | 0.376 0.005 DBMET02576 0.394 0.005 DBMET02577 | ||
| 0.454 | 0.048 | 0.493 | Antiobesity | 0.352 0.086 DBMET02576 0.493 0.039 DBMET02577 | DBMET02577 | |
| 0.402 | 0.004 | 0.402 | Cannabinoid receptor antagonist | 0.278 0.005 DBMET02576 0.253 0.005 DBMET02577 | ||
| 0.438 | 0.056 | 0.487 | Histamine release inhibitor | 0.487 0.033 DBMET02576 0.42 0.065 DBMET02577 | DBMET02576 | |
| 0.359 | 0.004 | 0.359 | Cannabinoid CB1 receptor antagonist | 0.226 0.005 DBMET02576 0.225 0.005 DBMET02577 | ||
| 0.352 | 0.005 | 0.352 | Histamine H1 receptor antagonist | 0.227 0.012 DBMET02576 0.249 0.009 DBMET02577 | ||
| 0.349 | 0.007 | 0.436 | NADPH oxidase inhibitor | 0.436 0.005 DBMET02576 0.32 0.01 DBMET02577 | DBMET02576 | |
| 0.351 | 0.01 | 0.351 | Nav1.2 sodium channel blocker | 0.293 0.016 DBMET02576 0.237 0.024 DBMET02577 | ||
| 0.331 | 0.011 | 0.331 | Neuropeptide Y2 antagonist | 0.33 0.011 DBMET02576 0.31 0.015 DBMET02577 | ||
| 0.327 | 0.008 | 0.327 | Calcium channel blocker | 0.23 0.021 DBMET02576 0.247 0.017 DBMET02577 | ||
| 0.319 | 0.005 | 0.319 | Calcium channel (voltage-sensitive) blocker | 0.201 0.017 DBMET02576 0.215 0.014 DBMET02577 | ||
| 0.317 | 0.005 | 0.317 | Nav1.6 sodium channel blocker | 0.254 0.009 DBMET02576 0.251 0.009 DBMET02577 | ||
| 0.314 | 0.003 | 0.314 | Calcium channel T-type blocker | 0.18 0.005 DBMET02576 0.144 0.007 DBMET02577 | ||
| 0.316 | 0.009 | 0.316 | Antihistaminic | 0.15 0.032 DBMET02576 0.218 0.018 DBMET02577 | ||
| 0.307 | 0.005 | 0.307 | Calcium channel N-type blocker | 0.216 0.013 DBMET02576 0.23 0.011 DBMET02577 | ||
| 0.307 | 0.009 | 0.307 | Histamine antagonist | 0.133 0.034 DBMET02576 0.206 0.018 DBMET02577 | ||
| 0.297 | 0.003 | 0.462 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.462 0.003 DBMET02576 0.105 0.009 DBMET02577 | DBMET02576 | |
| 0.298 | 0.009 | 0.298 | Nav1.3 sodium channel blocker | 0.219 0.019 DBMET02576 0.263 0.012 DBMET02577 | ||
| 0.297 | 0.015 | 0.297 | Antipruritic | 0.283 0.017 DBMET02576 0.236 0.029 DBMET02577 | ||
| 0.269 | 0.002 | 0.269 | Calcium channel P-type blocker | 0.217 0.002 DBMET02576 0.179 0.003 DBMET02577 | ||
| 0.324 | 0.061 | 0.399 | Spasmolytic | 0.364 0.049 DBMET02576 0.399 0.04 DBMET02577 | DBMET02577 | |
| 0.305 | 0.048 | 0.305 | HERG channel blocker | 0.16 0.12 DBMET02577 | ||
| 0.259 | 0.004 | 0.259 | Sphingosine 1-phosphate receptor 4 antagonist | 0.229 0.005 DBMET02576 0.249 0.005 DBMET02577 | ||
| 0.307 | 0.053 | 0.307 | Cardiotonic | 0.245 0.086 DBMET02576 0.279 0.065 DBMET02577 | ||
| 0.264 | 0.01 | 0.271 | ATPase inhibitor | 0.271 0.009 DBMET02576 0.194 0.042 DBMET02577 | DBMET02576 | |
| 0.311 | 0.061 | 0.402 | Hypoxia-inducible factor 1 alpha inhibitor | 0.402 0.029 DBMET02576 0.331 0.052 DBMET02577 | DBMET02576 | |
| 0.294 | 0.047 | 0.294 | Ca(v)3.3 blocker | 0.229 0.135 DBMET02576 0.206 0.179 DBMET02577 | ||
| 0.312 | 0.066 | 0.328 | 5 Hydroxytryptamine release stimulant | 0.328 0.062 DBMET02576 0.31 0.067 DBMET02577 | DBMET02576 | |
| 0.236 | 0.008 | 0.254 | Analgesic, opioid | 0.254 0.007 DBMET02576 0.172 0.012 DBMET02577 | DBMET02576 | |
| 0.342 | 0.122 | 0.366 | 5 Hydroxytryptamine release inhibitor | 0.366 0.102 DBMET02576 0.251 0.226 DBMET02577 | DBMET02576 | |
| 0.277 | 0.059 | 0.277 | 5 Hydroxytryptamine uptake stimulant | 0.272 0.062 DBMET02576 0.263 0.069 DBMET02577 | ||
| 0.303 | 0.085 | 0.349 | Vasodilator, coronary | 0.309 0.08 DBMET02576 0.349 0.056 DBMET02577 | DBMET02577 | |
| 0.233 | 0.025 | 0.233 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.085 DBMET02576 0.183 0.098 DBMET02577 | ||
| 0.238 | 0.031 | 0.317 | Heat shock protein 90 alpha antagonist | 0.317 0.012 DBMET02576 0.127 0.116 DBMET02577 | DBMET02576 | |
| 0.265 | 0.061 | 0.265 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.237 | 0.043 | 0.27 | Insulin sensitizer | 0.256 0.031 DBMET02576 0.27 0.025 DBMET02577 | DBMET02577 | |
| 0.204 | 0.012 | 0.204 | Nav1.5 sodium channel blocker | 0.153 0.025 DBMET02576 0.153 0.025 DBMET02577 | ||
| 0.212 | 0.021 | 0.212 | Alpha 2b adrenoreceptor antagonist | 0.179 0.029 DBMET02576 0.092 0.082 DBMET02577 | ||
| 0.202 | 0.013 | 0.202 | Calcium antagonist | 0.114 0.038 DBMET02576 0.138 0.027 DBMET02577 | ||
| 0.188 | 0.005 | 0.188 | CC chemokine 3 receptor antagonist | 0.105 0.009 DBMET02576 0.126 0.007 DBMET02577 | ||
| 0.206 | 0.025 | 0.206 | 5 Hydroxytryptamine 2B antagonist | 0.146 0.043 DBMET02576 0.153 0.04 DBMET02577 | ||
| 0.209 | 0.039 | 0.34 | Phospholipase C inhibitor | 0.271 0.021 DBMET02576 0.34 0.015 DBMET02577 | DBMET02577 | |
| 0.246 | 0.079 | 0.246 | 5 Hydroxytryptamine 1E antagonist | 0.237 0.089 DBMET02576 | ||
| 0.175 | 0.009 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.172 0.011 DBMET02576 0.166 0.017 DBMET02577 | ||
| 0.287 | 0.125 | 0.323 | GABA C receptor rho-3 antagonist | 0.323 0.101 DBMET02576 | DBMET02576 | |
| 0.182 | 0.022 | 0.182 | Alpha 2c adrenoreceptor antagonist | 0.158 0.029 DBMET02576 0.153 0.031 DBMET02577 | ||
| 0.167 | 0.007 | 0.188 | Lanosterol 14 alpha demethylase inhibitor | 0.159 0.009 DBMET02576 0.188 0.005 DBMET02577 | DBMET02577 | |
| 0.171 | 0.013 | 0.179 | Dopamine agonist | 0.179 0.012 DBMET02576 0.106 0.025 DBMET02577 | DBMET02576 | |
| 0.174 | 0.015 | 0.206 | Opioid delta receptor antagonist | 0.206 0.01 DBMET02576 0.142 0.021 DBMET02577 | DBMET02576 | |
| 0.174 | 0.019 | 0.207 | Opioid antagonist | 0.207 0.013 DBMET02576 0.145 0.028 DBMET02577 | DBMET02576 | |
| 0.161 | 0.009 | 0.161 | Dopamine uptake inhibitor | 0.12 0.014 DBMET02576 0.112 0.016 DBMET02577 | ||
| 0.171 | 0.025 | 0.171 | Chemokine receptor antagonist | 0.109 0.055 DBMET02576 0.119 0.048 DBMET02577 | ||
| 0.155 | 0.009 | 0.155 | Calcium channel L-type blocker | 0.107 0.021 DBMET02576 0.122 0.015 DBMET02577 | ||
| 0.157 | 0.013 | 0.157 | Acetylcholine release stimulant | 0.127 0.038 DBMET02576 0.135 0.028 DBMET02577 | ||
| 0.18 | 0.038 | 0.204 | Neurotrophic factor | 0.168 0.045 DBMET02576 0.204 0.026 DBMET02577 | DBMET02577 | |
| 0.189 | 0.047 | 0.189 | Acetylcholine M1 receptor antagonist | 0.187 0.048 DBMET02576 0.184 0.05 DBMET02577 | ||
| 0.232 | 0.093 | 0.317 | Interleukin agonist | 0.22 0.103 DBMET02576 0.317 0.04 DBMET02577 | DBMET02577 | |
| 0.183 | 0.049 | 0.26 | Lipid peroxidase inhibitor | 0.26 0.025 DBMET02576 0.197 0.043 DBMET02577 | DBMET02576 | |
| 0.14 | 0.008 | 0.16 | Opioid agonist | 0.16 0.007 DBMET02576 0.105 0.012 DBMET02577 | DBMET02576 | |
| 0.156 | 0.026 | 0.195 | Mediator release inhibitor | 0.195 0.015 DBMET02576 0.17 0.021 DBMET02577 | DBMET02576 | |
| 0.165 | 0.039 | 0.165 | Sphingosine 1-phosphate receptor 5 antagonist | 0.161 0.045 DBMET02576 0.144 0.071 DBMET02577 | ||
| 0.145 | 0.019 | 0.145 | CC chemokine receptor antagonist | 0.084 0.048 DBMET02576 0.097 0.037 DBMET02577 | ||
| 0.239 | 0.116 | 0.363 | 12-Lipoxygenase inhibitor | 0.363 0.052 DBMET02576 0.203 0.148 DBMET02577 | DBMET02576 | |
| 0.16 | 0.038 | 0.16 | Pregnane X receptor agonist | 0.152 0.05 DBMET02576 0.132 0.094 DBMET02577 | ||
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | 0.166 0.052 DBMET02576 0.154 0.061 DBMET02577 | ||
| 0.183 | 0.062 | 0.183 | 3C-like protease (Human coronavirus) inhibitor | 0.147 0.107 DBMET02576 0.143 0.113 DBMET02577 | ||
| 0.227 | 0.109 | 0.227 | Gastrin inhibitor | |||
| 0.158 | 0.04 | 0.158 | Antibacterial (Helicobacter pylori) | 0.152 0.044 DBMET02576 0.153 0.044 DBMET02577 | ||
| 0.171 | 0.055 | 0.253 | Heat shock protein 90 antagonist | 0.253 0.02 DBMET02576 | DBMET02576 | |
| 0.173 | 0.058 | 0.205 | Phospholipase A2 inhibitor | 0.205 0.04 DBMET02576 0.203 0.041 DBMET02577 | DBMET02576 | |
| 0.23 | 0.115 | 0.284 | Streptokinase A inhibitor | 0.284 0.086 DBMET02576 | DBMET02576 | |
| 0.163 | 0.048 | 0.163 | Acetylcholinesterase inhibitor | 0.151 0.055 DBMET02576 0.126 0.073 DBMET02577 | ||
| 0.119 | 0.005 | 0.119 | Potassium channel (Tandem pore domain) blocker | 0.085 0.024 DBMET02576 0.081 0.031 DBMET02577 | ||
| 0.141 | 0.027 | 0.141 | Dopamine antagonist | 0.131 0.029 DBMET02576 0.071 0.053 DBMET02577 | ||
| 0.117 | 0.004 | 0.233 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.233 0.003 DBMET02576 0.087 0.005 DBMET02577 | DBMET02576 | |
| 0.13 | 0.02 | 0.18 | Opioid kappa receptor antagonist | 0.18 0.012 DBMET02576 0.104 0.031 DBMET02577 | DBMET02576 | |
| 0.272 | 0.164 | 0.272 | MAP kinase kinase 6 inhibitor | |||
| 0.225 | 0.118 | 0.348 | Lipoxygenase inhibitor | 0.348 0.051 DBMET02576 0.263 0.091 DBMET02577 | DBMET02576 | |
| 0.137 | 0.033 | 0.137 | Multidrug resistance-associated protein 1 inhibitor | 0.132 0.037 DBMET02576 0.111 0.061 DBMET02577 | ||
| 0.258 | 0.153 | 0.258 | Beta lactamase inhibitor | |||
| 0.105 | 0.003 | 0.105 | Heme oxygenase inhibitor | 0.081 0.004 DBMET02576 0.094 0.003 DBMET02577 | ||
| 0.154 | 0.056 | 0.154 | Sodium channel blocker | 0.118 0.086 DBMET02577 | ||
| 0.118 | 0.02 | 0.118 | Dopamine D3 antagonist | 0.094 0.027 DBMET02576 0.055 0.05 DBMET02577 | ||
| 0.111 | 0.014 | 0.111 | Ca(v)3.1 blocker | 0.102 0.021 DBMET02576 0.081 0.058 DBMET02577 | ||
| 0.12 | 0.023 | 0.12 | Bromodomain-containing protein 2 inhibitor | 0.085 0.065 DBMET02576 0.085 0.066 DBMET02577 | ||
| 0.134 | 0.038 | 0.174 | AMP-activated protein kinase stimulant | 0.16 0.023 DBMET02576 0.174 0.016 DBMET02577 | DBMET02577 | |
| 0.123 | 0.028 | 0.123 | Alpha 2a adrenoreceptor antagonist | 0.11 0.032 DBMET02576 0.065 0.064 DBMET02577 | ||
| 0.246 | 0.153 | 0.246 | Calpain 2 inhibitor | |||
| 0.106 | 0.013 | 0.107 | Vanilloid 4 agonist | 0.083 0.035 DBMET02576 0.107 0.012 DBMET02577 | DBMET02577 | |
| 0.135 | 0.043 | 0.153 | TRPA1 agonist | 0.153 0.029 DBMET02576 | DBMET02576 | |
| 0.098 | 0.007 | 0.098 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.035 DBMET02576 | ||
| 0.104 | 0.014 | 0.104 | 5 Hydroxytryptamine 3 agonist | 0.083 0.025 DBMET02576 0.064 0.043 DBMET02577 | ||
| 0.111 | 0.021 | 0.111 | Acetylcholine M4 receptor antagonist | 0.068 0.059 DBMET02576 0.098 0.03 DBMET02577 | ||
| 0.117 | 0.027 | 0.23 | Macrophage migration inhibitory factor inhibitor | 0.23 0.006 DBMET02576 0.132 0.021 DBMET02577 | DBMET02576 | |
| 0.185 | 0.095 | 0.215 | Anticonvulsant | 0.215 0.073 DBMET02577 | DBMET02577 | |
| 0.142 | 0.053 | 0.142 | Anesthetic local | 0.123 0.064 DBMET02576 0.125 0.063 DBMET02577 | ||
| 0.101 | 0.013 | 0.101 | Melanin-concentrating hormone receptor 1 antagonist | 0.086 0.018 DBMET02577 | ||
| 0.231 | 0.146 | 0.327 | Apoptosis antagonist | 0.282 0.098 DBMET02576 0.327 0.068 DBMET02577 | DBMET02577 | |
| 0.1 | 0.016 | 0.125 | NMDA 2C receptor antagonist | 0.125 0.01 DBMET02576 0.061 0.043 DBMET02577 | DBMET02576 | |
| 0.103 | 0.018 | 0.114 | CC chemokine 5 receptor agonist | 0.114 0.011 DBMET02576 | DBMET02576 | |
| 0.135 | 0.051 | 0.135 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.193 | 0.11 | 0.2 | RNA-directed DNA polymerase inhibitor | 0.2 0.099 DBMET02576 0.195 0.106 DBMET02577 | DBMET02576 | |
| 0.13 | 0.048 | 0.13 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 DBMET02576 | ||
| 0.085 | 0.008 | 0.085 | CC chemokine receptor 2B antagonist | 0.067 0.014 DBMET02576 0.057 0.022 DBMET02577 | ||
| 0.083 | 0.006 | 0.1 | Opioid delta receptor agonist | 0.1 0.005 DBMET02576 0.059 0.01 DBMET02577 | DBMET02576 | |
| 0.08 | 0.004 | 0.08 | Nociceptin (N/OFQ) receptor agonist | 0.046 0.006 DBMET02576 0.063 0.005 DBMET02577 | ||
| 0.114 | 0.039 | 0.114 | Alpha 2 adrenoreceptor antagonist | 0.097 0.05 DBMET02576 0.078 0.069 DBMET02577 | ||
| 0.108 | 0.033 | 0.108 | Alpha 1b adrenoreceptor antagonist | 0.085 0.043 DBMET02576 | ||
| 0.088 | 0.013 | 0.101 | MDM2 inhibitor | 0.074 0.03 DBMET02576 0.101 0.006 DBMET02577 | DBMET02577 | |
| 0.091 | 0.017 | 0.091 | Cannabinoid CB2 receptor antagonist | 0.069 0.024 DBMET02576 0.051 0.036 DBMET02577 | ||
| 0.188 | 0.115 | 0.239 | Vasodilator | 0.218 0.091 DBMET02576 0.239 0.075 DBMET02577 | DBMET02577 | |
| 0.083 | 0.012 | 0.083 | Oleamide hydrolase inhibitor | 0.062 0.019 DBMET02576 0.081 0.013 DBMET02577 | ||
| 0.093 | 0.022 | 0.093 | Bcl2 antagonist | 0.079 0.033 DBMET02576 0.09 0.024 DBMET02577 | ||
| 0.122 | 0.052 | 0.122 | Sphingosine 1-phosphate receptor 2 agonist | 0.116 0.061 DBMET02576 0.104 0.09 DBMET02577 | ||
| 0.09 | 0.02 | 0.09 | Acetylcholine M5 receptor antagonist | 0.074 0.028 DBMET02576 0.078 0.025 DBMET02577 | ||
| 0.09 | 0.02 | 0.09 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.095 | 0.027 | 0.095 | Viral attachment inhibitor | 0.076 0.059 DBMET02576 0.087 0.036 DBMET02577 | ||
| 0.157 | 0.09 | 0.17 | Death-associated protein kinase 2 inhibitor | 0.17 0.069 DBMET02576 | DBMET02576 | |
| 0.091 | 0.023 | 0.091 | Cannabinoid CB1 receptor agonist | 0.071 0.034 DBMET02577 | ||
| 0.147 | 0.079 | 0.147 | Cholinergic | 0.122 0.105 DBMET02576 | ||
| 0.095 | 0.028 | 0.095 | Dopamine D4 antagonist | 0.072 0.036 DBMET02576 | ||
| 0.127 | 0.061 | 0.136 | Acetylcholine muscarinic antagonist | 0.127 0.061 DBMET02576 0.136 0.053 DBMET02577 | DBMET02577 | |
| 0.107 | 0.041 | 0.107 | Alpha 1 adrenoreceptor antagonist | 0.076 0.055 DBMET02576 | ||
| 0.098 | 0.033 | 0.098 | Dopamine D2 antagonist | 0.09 0.035 DBMET02576 | ||
| 0.078 | 0.014 | 0.078 | 5 Hydroxytryptamine 7 agonist | 0.072 0.017 DBMET02576 | ||
| 0.081 | 0.017 | 0.081 | Glycine transporter inhibitor | 0.043 0.037 DBMET02576 0.044 0.037 DBMET02577 | ||
| 0.238 | 0.175 | 0.364 | 15-Lipoxygenase inhibitor | 0.364 0.092 DBMET02576 | DBMET02576 | |
| 0.074 | 0.013 | 0.074 | Chemokine receptor agonist | 0.044 0.04 DBMET02576 0.068 0.02 DBMET02577 | ||
| 0.132 | 0.071 | 0.132 | Sodium channel (voltage-gated) blocker | 0.109 0.099 DBMET02577 | ||
| 0.23 | 0.171 | 0.23 | Calcium channel activator | 0.215 0.191 DBMET02576 | ||
| 0.091 | 0.035 | 0.135 | Opioid mu receptor antagonist | 0.135 0.021 DBMET02576 0.071 0.045 DBMET02577 | DBMET02576 | |
| 0.082 | 0.026 | 0.113 | Aromatase inhibitor | 0.113 0.019 DBMET02576 0.077 0.029 DBMET02577 | DBMET02576 | |
| 0.138 | 0.085 | 0.142 | Neuropeptide Y1 antagonist | 0.142 0.077 DBMET02576 | DBMET02576 | |
| 0.062 | 0.01 | 0.062 | Nociceptin (N/OFQ) receptor antagonist | 0.047 0.016 DBMET02576 0.048 0.015 DBMET02577 | ||
| 0.09 | 0.04 | 0.09 | Alpha 1a adrenoreceptor antagonist | 0.062 0.056 DBMET02576 | ||
| 0.195 | 0.145 | 0.22 | Transcription factor STAT inhibitor | 0.22 0.112 DBMET02576 | DBMET02576 | |
| 0.069 | 0.021 | 0.069 | Dopamine transporter inhibitor | 0.047 0.034 DBMET02576 0.045 0.037 DBMET02577 | ||
| 0.137 | 0.088 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.053 DBMET02576 0.133 0.104 DBMET02577 | DBMET02576 | |
| 0.085 | 0.037 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.037 DBMET02576 0.09 0.03 DBMET02577 | DBMET02577 | |
| 0.166 | 0.119 | 0.166 | Potassium channel blocker | |||
| 0.101 | 0.058 | 0.171 | Creatine kinase inhibitor | 0.171 0.016 DBMET02576 | DBMET02576 | |
| 0.1 | 0.057 | 0.1 | Alpha adrenoreceptor antagonist | 0.079 0.073 DBMET02576 | ||
| 0.24 | 0.199 | 0.258 | DNA polymerase beta inhibitor | 0.258 0.187 DBMET02576 | DBMET02576 | |
| 0.189 | 0.149 | 0.209 | Transcription factor STAT3 inhibitor | 0.209 0.122 DBMET02576 | DBMET02576 | |
| 0.058 | 0.018 | 0.075 | CC chemokine 4 receptor antagonist | 0.075 0.008 DBMET02577 | DBMET02577 | |
| 0.066 | 0.028 | 0.066 | CC chemokine 2 receptor antagonist | |||
| 0.234 | 0.197 | 0.365 | Alpha-glucosidase inhibitor | 0.365 0.129 DBMET02576 | DBMET02576 | |
| 0.061 | 0.025 | 0.061 | CC chemokine 5 receptor antagonist | 0.047 0.04 DBMET02577 | ||
| 0.046 | 0.011 | 0.046 | Glutamate (mGluR8) antagonist | 0.043 0.014 DBMET02576 0.046 0.011 DBMET02577 | ||
| 0.074 | 0.039 | 0.074 | Acetylcholine M5 receptor agonist | |||
| 0.062 | 0.027 | 0.076 | Sphingosine 1-phosphate receptor 1 antagonist | 0.061 0.027 DBMET02576 0.076 0.015 DBMET02577 | DBMET02577 | |
| 0.046 | 0.012 | 0.049 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.048 0.01 DBMET02576 0.049 0.009 DBMET02577 | DBMET02577 | |
| 0.11 | 0.076 | 0.137 | Cholesterol synthesis inhibitor | 0.137 0.052 DBMET02576 0.098 0.089 DBMET02577 | DBMET02576 | |
| 0.049 | 0.016 | 0.06 | GABA uptake inhibitor | 0.042 0.024 DBMET02576 0.06 0.01 DBMET02577 | DBMET02577 | |
| 0.072 | 0.038 | 0.115 | Dopamine D1 antagonist | 0.115 0.021 DBMET02576 0.059 0.051 DBMET02577 | DBMET02576 | |
| 0.088 | 0.054 | 0.088 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.2 | 0.168 | 0.268 | Caspase 3 stimulant | 0.268 0.098 DBMET02576 0.262 0.102 DBMET02577 | DBMET02576 | |
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.076 | 0.046 | 0.136 | NMDA 2 receptor antagonist | 0.136 0.019 DBMET02576 | DBMET02576 | |
| 0.066 | 0.037 | 0.066 | Alpha 1d adrenoreceptor antagonist | |||
| 0.11 | 0.083 | 0.123 | Cholinergic antagonist | 0.103 0.091 DBMET02576 0.123 0.071 DBMET02577 | DBMET02577 | |
| 0.112 | 0.086 | 0.21 | Amylase inhibitor | 0.21 0.041 DBMET02576 0.205 0.043 DBMET02577 | DBMET02576 | |
| 0.041 | 0.015 | 0.041 | CXC chemokine receptor agonist | 0.037 0.02 DBMET02577 | ||
| 0.059 | 0.033 | 0.099 | Sphingosine kinase 2 inhibitor | 0.065 0.026 DBMET02576 0.099 0.008 DBMET02577 | DBMET02577 | |
| 0.051 | 0.026 | 0.051 | Histamine H3 receptor antagonist | |||
| 0.064 | 0.04 | 0.064 | Adrenaline uptake inhibitor | |||
| 0.144 | 0.123 | 0.155 | Non-steroidal antiinflammatory agent | 0.154 0.11 DBMET02576 0.155 0.109 DBMET02577 | DBMET02577 | |
| 0.068 | 0.048 | 0.068 | Exportin-1 inhibitor | |||
| 0.028 | 0.01 | 0.032 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.032 0.009 DBMET02576 | DBMET02576 | |
| 0.039 | 0.021 | 0.039 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.042 | 0.025 | 0.042 | Acid-sensing ion channel blocker | 0.039 0.03 DBMET02576 | ||
| 0.098 | 0.081 | 0.098 | 5 Hydroxytryptamine antagonist | |||
| 0.078 | 0.061 | 0.078 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.104 | 0.087 | 0.116 | Acetylcholine antagonist | 0.098 0.095 DBMET02576 0.116 0.074 DBMET02577 | DBMET02577 | |
| 0.053 | 0.036 | 0.053 | Dipeptidyl peptidase inhibitor | |||
| 0.026 | 0.011 | 0.035 | Geranylgeranyltransferase inhibitor | 0.035 0.007 DBMET02577 | DBMET02577 | |
| 0.118 | 0.103 | 0.166 | Cell wall synthesis inhibitor | 0.124 0.094 DBMET02576 0.166 0.051 DBMET02577 | DBMET02577 | |
| 0.026 | 0.012 | 0.026 | Urotensin II antagonist | |||
| 0.223 | 0.21 | 0.248 | DNA directed DNA polymerase inhibitor | 0.248 0.193 DBMET02576 | DBMET02576 | |
| 0.035 | 0.022 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.044 | 0.031 | 0.044 | Dipeptidyl peptidase IV inhibitor | |||
| 0.048 | 0.035 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DBMET02576 0.047 0.037 DBMET02577 | DBMET02576 | |
| 0.033 | 0.02 | 0.033 | CXC chemokine 3 receptor antagonist | |||
| 0.035 | 0.023 | 0.035 | Adenosine uptake inhibitor | |||
| 0.035 | 0.025 | 0.062 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET02576 0.062 0.004 DBMET02577 | DBMET02577 | |
| 0.055 | 0.045 | 0.055 | Pregnane X receptor antagonist | |||
| 0.039 | 0.029 | 0.048 | CF transmembrane conductance regulator antagonist | 0.046 0.013 DBMET02576 0.048 0.01 DBMET02577 | DBMET02577 | |
| 0.018 | 0.008 | 0.018 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.034 | 0.024 | 0.034 | Carnitine palmitoyltransferase inhibitor | |||
| 0.069 | 0.059 | 0.069 | Orexin receptor 1 antagonist | |||
| 0.14 | 0.131 | 0.149 | Succinate dehydrogenase inhibitor | 0.149 0.114 DBMET02576 0.148 0.116 DBMET02577 | DBMET02576 | |
| 0.056 | 0.047 | 0.07 | Acetylcholine M3 receptor antagonist | 0.067 0.034 DBMET02576 0.07 0.031 DBMET02577 | DBMET02577 | |
| 0.083 | 0.074 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.095 0.06 DBMET02576 0.173 0.018 DBMET02577 | DBMET02577 | |
| 0.084 | 0.075 | 0.123 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.123 0.037 DBMET02577 | DBMET02577 | |
| 0.014 | 0.006 | 0.017 | Egl nine homolog 3 inhibitor | 0.017 0.005 DBMET02576 | DBMET02576 | |
| 0.104 | 0.096 | 0.111 | Transcription factor STAT6 inhibitor | 0.111 0.077 DBMET02576 | DBMET02576 | |
| 0.116 | 0.108 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.019 | 0.011 | 0.019 | Apolipoprotein B-100 inhibitor | |||
| 0.045 | 0.038 | 0.045 | Sigma receptor antagonist | |||
| 0.084 | 0.078 | 0.084 | DNA directed RNA polymerase inhibitor | |||
| 0.018 | 0.012 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.088 | 0.083 | 0.092 | Falcipain 3 inhibitor | 0.092 0.079 DBMET02577 | DBMET02577 | |
| 0.022 | 0.018 | 0.024 | ICAM 1 antagonist | 0.024 0.013 DBMET02577 | DBMET02577 | |
| 0.042 | 0.038 | 0.043 | Farnesyltransferase inhibitor | 0.043 0.037 DBMET02577 | DBMET02577 | |
| 0.039 | 0.035 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.029 DBMET02577 | DBMET02577 | |
| 0.082 | 0.079 | 0.148 | 5-Lipoxygenase inhibitor | 0.148 0.038 DBMET02576 0.104 0.061 DBMET02577 | DBMET02576 | |
| 0.03 | 0.027 | 0.03 | Dipeptidyl peptidase II inhibitor | |||
| 0.04 | 0.039 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.057 | 0.058 | 0.067 | Sphingosine 1-phosphate receptor 4 agonist | 0.067 0.047 DBMET02577 | DBMET02577 | |
| 0.04 | 0.041 | 0.062 | Opioid mu receptor agonist | 0.062 0.023 DBMET02576 | DBMET02576 | |
| 0.039 | 0.042 | 0.051 | Carbonic anhydrase VII inhibitor | 0.051 0.027 DBMET02576 | DBMET02576 | |
| 0.012 | 0.015 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.009 DBMET02576 | DBMET02576 | |
| 0.012 | 0.016 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DBMET02576 | DBMET02576 | |
| 0.141 | 0.148 | 0.295 | Aldehyde oxidase inhibitor | 0.295 0.068 DBMET02576 | DBMET02576 | |
| 0.163 | 0.172 | 0.182 | Nitric-oxide synthase stimulant | 0.174 0.142 DBMET02576 0.182 0.123 DBMET02577 | DBMET02577 | |
| 0.046 | 0.058 | 0.053 | Thromboxane synthase inhibitor | 0.053 0.042 DBMET02577 | DBMET02577 | |
| 0.176 | 0.188 | 0.317 | Cholesterol antagonist | 0.234 0.137 DBMET02576 0.317 0.081 DBMET02577 | DBMET02577 | |
| 0.03 | 0.043 | 0.082 | Estradiol 17 beta-dehydrogenase inhibitor | 0.082 0.013 DBMET02576 | DBMET02576 | |
| 0.032 | 0.047 | 0.044 | Opioid kappa receptor agonist | 0.044 0.029 DBMET02576 | DBMET02576 | |
| 0.036 | 0.05 | 0.061 | Thromboxane A2 antagonist | 0.061 0.028 DBMET02577 | DBMET02577 | |
| 0.111 | 0.126 | 0.131 | Insulin secretagoues | 0.127 0.101 DBMET02576 0.131 0.095 DBMET02577 | DBMET02577 | |
| 0.038 | 0.057 | 0.062 | Thromboxane antagonist | 0.062 0.031 DBMET02577 | DBMET02577 | |
| 0.138 | 0.158 | 0.191 | Neurotrophic factor enhancer | 0.191 0.086 DBMET02576 0.155 0.131 DBMET02577 | DBMET02576 | |
| 0.082 | 0.102 | 0.152 | Cystathionine beta-synthase inhibitor | 0.152 0.04 DBMET02576 | DBMET02576 | |
| 0.172 | 0.195 | 0.219 | Tyrosine 3 hydroxylase inhibitor | 0.219 0.104 DBMET02576 | DBMET02576 | |
| 0.022 | 0.045 | 0.031 | Estrogen-related receptor gamma antagonist | 0.031 0.015 DBMET02576 | DBMET02576 | |
| 0.09 | 0.12 | 0.109 | Cyclooxygenase 3 inhibitor | 0.109 0.09 DBMET02576 | DBMET02576 | |
| 0.089 | 0.12 | 0.165 | Alpha-N-acetylglucosaminidase inhibitor | 0.165 0.047 DBMET02577 | DBMET02577 | |
| 0.063 | 0.096 | 0.076 | GABA B receptor agonist | 0.076 0.051 DBMET02576 | DBMET02576 | |
| 0.064 | 0.097 | 0.102 | Potassium channel (Ca-activated) activator | 0.102 0.054 DBMET02576 | DBMET02576 | |
| 0.069 | 0.104 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.053 DBMET02577 | DBMET02577 | |
| 0.076 | 0.111 | 0.093 | Bile acid receptor antagonist | 0.093 0.066 DBMET02576 | DBMET02576 | |
| 0.044 | 0.09 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET02576 | DBMET02576 | |
| 0.042 | 0.093 | 0.066 | Sphingosine kinase inhibitor | 0.066 0.03 DBMET02577 | DBMET02577 | |
| 0.041 | 0.095 | 0.104 | Leukotriene synthesis inhibitor | 0.059 0.056 DBMET02576 0.104 0.024 DBMET02577 | DBMET02577 | |
| 0.167 | 0.224 | 0.259 | Antithrombotic | 0.259 0.119 DBMET02577 | DBMET02577 | |
| 0.026 | 0.085 | 0.042 | Sphingosine kinase 1 inhibitor | 0.042 0.027 DBMET02577 | DBMET02577 | |
| 0.036 | 0.097 | 0.055 | Autotaxin inhibitor | 0.055 0.033 DBMET02577 | DBMET02577 | |
| 0.027 | 0.09 | 0.063 | Prostaglandin E2 antagonist | 0.063 0.027 DBMET02577 | DBMET02577 | |
| 0.053 | 0.117 | 0.085 | NMDA receptor antagonist | 0.085 0.06 DBMET02576 | DBMET02576 | |
| 0.104 | 0.168 | 0.123 | Adenylate cyclase stimulant | 0.123 0.117 DBMET02576 | DBMET02576 | |
| 0.094 | 0.158 | 0.141 | Mcl-1 antagonist | 0.141 0.099 DBMET02576 | DBMET02576 | |
| 0.074 | 0.14 | 0.112 | Cyclooxygenase 1 inhibitor | 0.112 0.088 DBMET02576 | DBMET02576 | |
| 0.069 | 0.146 | 0.1 | Beta glucuronidase inhibitor | 0.1 0.07 DBMET02576 | DBMET02576 | |
| 0.065 | 0.142 | 0.084 | Estrogen-related receptor beta agonist | 0.084 0.054 DBMET02576 | DBMET02576 | |
| 0.091 | 0.169 | 0.113 | DNA repair enzyme inhibitor | 0.113 0.087 DBMET02577 | DBMET02577 | |
| 0.044 | 0.122 | 0.062 | Interferon inducer | 0.062 0.048 DBMET02577 | DBMET02577 | |
| 0.093 | 0.177 | 0.138 | Farnesoid X receptor antagonist | 0.138 0.068 DBMET02576 | DBMET02576 | |
| 0.067 | 0.155 | 0.087 | Glutamate release inhibitor | 0.087 0.07 DBMET02577 | DBMET02577 | |
| 0.057 | 0.15 | 0.079 | Triose-phosphate isomerase inhibitor | 0.079 0.078 DBMET02577 | DBMET02577 | |
| 0.073 | 0.167 | 0.101 | Aldehyde dehydrogenase inhibitor | 0.101 0.096 DBMET02576 | DBMET02576 | |
| 0.062 | 0.156 | 0.077 | D-Ala-D-Ala ligase inhibitor | 0.077 0.076 DBMET02576 | DBMET02576 | |
| 0.065 | 0.161 | 0.093 | Carbonic anhydrase XV inhibitor | 0.093 0.078 DBMET02577 | DBMET02577 | |
| 0.116 | 0.214 | 0.14 | Neurotensin receptor agonist | 0.14 0.128 DBMET02576 | DBMET02576 | |
| 0.102 | 0.201 | 0.127 | CF transmembrane conductance regulator agonist | 0.127 0.124 DBMET02576 | DBMET02576 | |
| 0.079 | 0.183 | 0.111 | Protein kinase stimulant | 0.111 0.103 DBMET02577 | DBMET02577 | |
| 0.044 | 0.152 | 0.073 | Interferon agonist | 0.073 0.064 DBMET02577 | DBMET02577 | |
| 0.091 | 0.217 | 0.131 | Melanin inhibitor | 0.131 0.113 DBMET02576 | DBMET02576 | |
| 0.078 | 0.211 | 0.134 | Pyruvate kinase inhibitor | 0.134 0.132 DBMET02576 | DBMET02576 | |
| 0.016 | 0.159 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 DBMET02576 | DBMET02576 | |
| 0.04 | 0.2 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET02577 | DBMET02577 | |
| 0.073 | 0.327 | 0.213 | Antioxidant | 0.213 0.105 DBMET02576 | DBMET02576 | |
| 0.047 | 0.303 | 0.132 | Amyloid beta aggregation inhibitor | 0.132 0.124 DBMET02576 | DBMET02576 | |
| 0.047 | 0.389 | 0.192 | Free radical scavenger | 0.192 0.105 DBMET02576 | DBMET02576 | |
| 0.035 | 0.406 | 0.128 | Estrogen antagonist | 0.128 0.042 DBMET02576 | DBMET02576 | |
| 0.024 | 0.419 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET02576 | DBMET02576 | |
| 0.015 | 0.488 | 0.091 | Bronchodilator | 0.091 0.073 DBMET02577 | DBMET02577 | |
| 0.076 | 0.62 | 0.266 | Interleukin 2 agonist | 0.266 0.102 DBMET02577 | DBMET02577 | |
| 0.054 | 0.622 | 0.248 | Cyclophilin D inhibitor | 0.248 0.216 DBMET02577 | DBMET02577 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |